A lung cancer drug developed by Akeso Inc. extended patients’ lives by about four months in a late-stage trial in China, ...

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for ...

Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.

Daily pill almost doubles survival time for pancreatic cancer patients in new trial - Daraxonrasib has been hailed as ...

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy ...

A new DNA test could help screen whether patients require the treatment or not, according to a new international trial.

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...

Millions of people with breast cancer could safely avoid chemotherapy as scientists have developed a groundbreaking DNA test.

Massachusetts General Hospital's SMART program helps other deal with what comes after their cancer diagnosis.